维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="LESPRIT P"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Hospital antibiotic stewardship 显示文摘	Lesprit P Brun - Buisson C	2008	Curr Opin Infect Dis2008，21，4：	1
2	Acute arterial obliteration: a new feature of the POEMS syndrome显示文摘	Lesprit P Authier FJ Gherardi R	1996	Medicine1996，75，4：	1
3	Management of multidrug resistant bacterial en- demic 显示文摘	Zahar JR Lesprit P	2014	Med Mal Infect2014，44，9：	1
4	Pulmonary hypertension in POEMS syndrome:A new feature mediated by cytokines显示文摘	Lesprit P Godeau B Authier FJ	1998	Am J Respir Crit Care Med1998，157，3：	1
5	Acute arterial obliteration:A new feature of the POEMS syndrome?显示文摘	Lesprit P Authier FJ Gherardi R	1996	Medicine1996，75，4：	1
6	In vivo selection during ofloxacin therapy of Escherichia coli with combined topot somer ase mutations that confer high resistance to ofloxacin but suscep- tibility to nalidixic acid显示文摘	Cattoir V Lesprit P Lascols C	2006	J Antimicrob Chemother2006，58，5：	1
7	Positive blood culture in hos- pital: Notification methods and impact of recommendations by an in- fectious disease specialist显示文摘	Gros H Aslangul E Lesprit P	2012	Med Mal Infect2012，42，2：	1
8	In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid显示文摘	Cattoir V Lesprit P Lascols C	2006	J Antimicrob Chemother2006，58，5：	1
9	Protracted outbreakofmultidrug- baumannii after intereontinentaltransfer of colonized patients 显示文摘	Landelle C Legrand P Lesprit P	2013	Infect Control Hosp Epidemiol2013，34，2：	1
10	In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid显示文摘	Cattoir V Lesprit P Lascols C		0，，05：	1
11	In vivo selection during ofloxacin therapy of Escherichia coli with combined to poisomerasemu-tations that confer high resistance to ofloxacin but susceptibility to nali-dixic acid显示文摘	Cattoir V Lesprit P Lascols C	2006	J Antimicrob Chemother2006，58，5：	1
12	Tuberculosis treatment duration in France:From guidelines to daily practice显示文摘	P Tattevin JM Chapplain P Lesprit	2006	European Journal of Internal Medicine2006，17，：	1
13	Hospital antibiotic stewardship显示文摘	Lesprit P Brun-Buisson C	2008	Curr Opin Infect Dis2008，21，4：	1
14	Pucmonary hypertension in POEMS, a now feature mediated by cytokines显示文摘	Lesprit P Godeau B Authier FJ	1998	Am J Respir Crit Care Med1998，15，3：	1
15	In vivo selection during ofloxacin therapy of Escherichia coli with combined to poisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid显示文摘	CATTOIR V LESPRIT P LASCOLS C	2006	J Antimicrob Chemother2006，58，5：	1
16	In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid 显示文摘	Cattoir V Lesprit P Lascols C	2006	J Antimicrob Chemother2006，58，：	1
17	Pulmonary hypertension in POEMS syndrome:a new feature mediated by cytokines显示文摘	Lesprit P Godeau B Bertrand G	1998	Am J Respir Crit Care Med1998，157，31：	1
18	Positive blood culture inhospital:Notification methods and impact of recommenda-tions by an infectious disease specialist显示文摘	Gros H Aslangul E Lesprit P	2012	Médecine et Mala-dies Infectieuses2012，42，2：	1
19	Acute arterial obliteration: a new feature of the POEMS syndrome 显示文摘	Lesprit P Authier FJ Gherardi R	1996	Medicine (Baltimore)1996，75，4：	1
20	Acute arterial obliteration:a new feature of the POEMS syndrome显示文摘	Lesprit P Authier FJ Gherardi R	1996	Medicine(Baltimore)1996，75，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示